A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a pediatric psoriasis population

Pediatric Dermatology
Amy S PallerGregory Kricorian

Abstract

Compared with the adult psoriasis population, knowledge about the incidence of comorbidities in the pediatric psoriasis population is limited. The objective of this study was to assess the prevalence and incidence of comorbidities, including psychiatric comorbidities, in patients with pediatric psoriasis. In this claims-based, retrospective cohort study, patients with pediatric psoriasis were matched 1:3 with a nonpsoriasis cohort based on age, sex, and index date (the earliest of inpatient claims or the latter of two outpatient claims). Obesity, serious infection, and juvenile idiopathic arthropathy had higher prevalence and incidence rates in the psoriasis cohort than the nonpsoriasis cohort. Psychiatric comorbidities were also more common in the psoriasis cohort than the nonpsoriasis cohort, as were ulcerative colitis and Crohn disease. Stratifying the psoriasis cohort by disease severity-mild and moderate-to-severe-found no differences in incidence rates of comorbidities between the two subsets. The incidence rates of many comorbid conditions were higher for patients with pediatric psoriasis compared with patients without pediatric psoriasis, and similar between patients with moderate-to-severe and mild pediatric psoriasis.

References

Jul 15, 2004·The Australasian Journal of Dermatology·Paul A J RussoAlan J Cooper
Aug 10, 2005·The British Journal of Dermatology·A O OlsenJ R Harris
Dec 21, 2005·Archives of Dermatology·Joel M GelfandDavid J Margolis
Jan 18, 2008·The New England Journal of Medicine·Amy S PallerUNKNOWN Etanercept Pediatric Psoriasis Study Group
Oct 7, 2008·Journal of the American Academy of Dermatology·Murat IcenHilal Maradit Kremers
Jun 13, 2009·The British Journal of Dermatology·D BoccardiM Ferraroni
Nov 10, 2009·Therapeutics and Clinical Risk Management·Nanette B Silverberg
Nov 20, 2009·The British Journal of Dermatology·M AugustinI Schäfer
Nov 17, 2010·Pediatric Dermatology·Ayhan BilgicEmine Zinnur Kılıç
Jan 17, 2012·Journal of the American Academy of Dermatology·Alexa B KimballParvez M Mulani
May 16, 2012·Journal of the American Academy of Dermatology·Shiu-chung AuAlice B Gottlieb
May 3, 2013·Pharmacoepidemiology and Drug Safety·Maryam M AsgariLisa J Herrinton
Sep 11, 2013·Pediatric Dermatology·Ari M GoldminzAlice B Gottlieb
Mar 19, 2014·Pediatric Clinics of North America·Megha M Tollefson
Jun 15, 2015·Paediatric Drugs·I M G J BronckersM M B Seyger
Jul 28, 2015·The Journal of Investigative Dermatology·Junko TakeshitaJalpa A Doshi
Feb 13, 2016·Pediatric Dermatology·Daniel M KlufasBruce E Strober
Mar 2, 2016·The British Journal of Dermatology·E Burden-TehR Murphy
May 18, 2017·JAMA Dermatology·Emily OsierLawrence F Eichenfield
Jun 18, 2017·Journal of the American Academy of Dermatology·Kamal ShahSteven R Feldman
Oct 2, 2017·Journal of the American Academy of Dermatology·Lauren KwaJonathan I Silverberg
Jul 20, 2018·Pediatric Dermatology·Manrup K HunjanMegha Tollefson

❮ Previous
Next ❯

Citations

May 22, 2021·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·Bianca Y KangIsrael D Andrews
Jun 10, 2021·Expert Opinion on Biological Therapy·Jennifer Clay CatherJ Christian Cather
Jul 9, 2021·Psoriasis : Targets and Therapy·Parichat Mhusakunchai, Leelawadee Techasatian
Aug 25, 2021·Dermatologic Therapy·Matteo MegnaGabriella Fabbrocini
Dec 11, 2021·Pediatric Dermatology·Helen Y SunDeshan F Sebaratnam

❮ Previous
Next ❯

Software Mentioned

MarketScan

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft für Kinderheilkunde
F Bläker
Medizinische Monatsschrift für Pharmazeuten
M Fellhauer
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
H Asakura
© 2022 Meta ULC. All rights reserved